Most of plasma cell myelomas are CD19-, CD45-/dim positive, CD38+++ and CD138+, while CD19 positivity is seen in lymphomas including the marginal zone lymphoma or lymphoplasmacytic lymphoma. This evidence concerns the gene PTPRC and plasma cell myeloma.